The neurochemical effects of the unique psychedelic agent, methylenedioxymethamphetamine (MDMA), indicate it may be a serotonergic neurotoxin related to agents such as p-chloroamphetamine. MDMA had a biphasic effect on cortical serotonin concentrations beginning with an acute depletion of the transmitter which reached a maximum between 3 and 6 hr after drug administration. This early phase of...
Recently, attention has been focused on (+/-)-methylenedioxymethamphetamine (MDMA), a psychotomimetic agent chemically closely related to the psychomotor stimulant methamphetamine, and also to the hallucinogen mescaline. In the present experiment, the effects of MDMA and (+/-)-3,4-methylenedioxyamphetamine (MDA) were determined in rhesus monkeys that were trained to discriminate intravenously...
The experimental subjects were older than the average general population, more educated and considerably experienced in drug use. They considered themselves to have benefited by their MDMA experience, with no evidence of harm. There were moderate, consistent biochemical, cardiovascular and neurobehavioral changes within normal limits that peaked between one and two hours following ingestion,...
(1986). Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens. Journal of Psychoactive Drugs: Vol. 18, MDMA: Proceedings of the Conference, pp. 305-313.
(1986). Subjective Reports of the Effects of MDMA in a Clinical Setting. Journal of Psychoactive Drugs: Vol. 18, MDMA: Proceedings of the Conference, pp. 319-327.
This article discusses the competing definitions and issues surrounding the various desgner drugs, but is primarily devoted t o an examination of MDMA, an increasingly popular substance often labeled as a designer drug. Also known as “Ecstasy” or “Adam,” MDMA possesses both stimulant and psychedelic properties which combine to produce a unique effect desired by many users. The authors offer a...